Moderna Inc’s experimental vaccine was 94.5% effective in preventing Covid-19 based on interim data from a late-stage trial, the company said Monday, becoming the second U.S. pharmacist to report results that far exceed those. expectations. Along with Pfizer Inc’s vaccine, which is also more than 90% effective, and pending more …
Read More »
Pfizer, Moderna, Novavax: executives from several US laboratories developing COVID-19 Vaccines have recently raked in millions of dollars by selling shares in their companies, raising questions about the advisability of such a move amid a national health crisis. On the same day that pharmaceutical giant Pfizer announced preliminary data showing …
Read More »
The stakes are high for the results of Moderna Inc.’s upcoming Covid-19 vaccine trial.But when it comes to investors, the impact may already be on the price of financial assets. The bar was raised for markets to rebound following an announcement by Pfizer Inc. that its vaccine protected 90% of …
Read More »
NEW DELHI: India moved forward with work on its coronavirus vaccine, while Britain ‘s AstraZeneca It said its deliveries were being delayed “a bit” as countries around the world sought to conquer the pandemic and rescue their economies. A vaccine It is considered the world’s best bet to tame a …
Read More »
By: Desk Explained | Pune | Updated: October 6, 2020 9:21:50 am Travelers wearing masks wait at a traffic intersection in Kochi, Kerala (AP) Coronavirus Vaccine Tracker: India is working to vaccinate 20 to 25 million million of its population, about one sixth of its total population, against Covid19 disease …
Read More »
An effective vaccine may be the only real protection against Covid-19 as it stands, but don’t pin your hopes on getting it anytime soon. As India’s death toll from Covid surpasses one lakh, knowledge from the scientific community and government officials suggest that it could take up to two years …
Read More »
A successful vaccine for Covid-19 is not enough to prevent the spread of the coronavirus and many challengers would have to be overcome to implement a successful vaccination program, a recent study warned. A report from the Royal Society’s DELVE (Data Assessment and Learning for Viral Epidemics) initiative suggests that …
Read More »
By: Desk Explained | Updated: October 2, 2020 9:03:24 am President Donald Trump arrives to speak at a press conference in the James Brady Press Conference Room of the White House, Friday, Sept. 18, 2020, in Washington, as Army General Gustave Perna, who leads Operation, watches. Warp Speed. (AP Photo …
Read More »
The American biotech firm Moderna will not seek an emergency use authorization for its coronavirus vaccine before November 25, its CEO told the Financial Times on Wednesday. The news deals a blow to President Donald Trump’s hopes of having an injection ready before the election to give his campaign a …
Read More »
Meanwhile, the US Food and Drug Administration has expanded its investigation of a serious illness into the AstraZeneca Plc Covid-19 vaccine study and will analyze data from previous trials of similar vaccines developed by the same scientists, three sources familiar with the details told Reuters. The large late-stage American trial …
Read More »